Biological Psychiatry

Biological Psychiatry(英文缩写 BIOL PSYCHIAT),ISSN 0006-3223,eISSN 1873-2402 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

指标来源：jcr_cas_ifqb

历年影响因子趋势

Biological Psychiatry 最新收录文献

1. The pharmacogenetics of major depression: past, present, and future.
   Gonzalo Laje, Francis J McMahon
   Biological psychiatry 2007 IF: 10.30 Q1 PMID: 17949692
   查看详情 DOI
2. A longitudinal typology of symptoms of depression and anxiety over the life course.
   Ian Colman, George B Ploubidis, Michael E J Wadsworth, Peter B Jones, Tim J Croudace
   Biological psychiatry 2007 IF: 10.30 Q1 PMID: 17692292

   Little is known about long-term profiles of depressive and anxious symptomatology over the life course and about the developmental determinants of different trajectories. The objective of this study w…

   查看详情 DOI
3. Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression.
   Jennifer C Felger, Oyetunde Alagbe, Fang Hu, Deborah Mook, Amanda A Freeman, Mar M Sanchez
   Biological psychiatry 2007 IF: 10.30 Q1 PMID: 17678633

   Interferon (IFN)-alpha is an innate immune cytokine that causes high rates of depression in humans and therefore has been used to study the impact of cytokines on the brain and behavior. To establish …

   查看详情 DOI
4. Direct inhibitory effect of fluoxetine on N-methyl-D-aspartate receptors in the central nervous system.
   Bernadett K Szasz, Arpad Mike, Robert Karoly, Zoltan Gerevich, Peter Illes, E Sylvester Vizi
   Biological psychiatry 2007 IF: 10.30 Q1 PMID: 17659262

   Data accumulated in the last decade indicate that N-methyl-D-aspartate (NMDA) receptors might be involved in the pathophysiology of depression and the mechanism of action of antidepressants, although …

   查看详情 DOI
5. Glucocorticoid receptor antagonists hasten and augment neurochemical responses to a selective serotonin reuptake inhibitor antidepressant.
   Daniel A Johnson, Emma J Grant, Colin D Ingram, Sarah E Gartside
   Biological psychiatry 2007 IF: 10.30 Q1 PMID: 17651703

   Selective serotonin reuptake inhibitor (SSRI) antidepressant drugs have a delayed onset and commonly produce an incomplete therapeutic response. The therapeutic actions of SSRIs are thought to depend …

   查看详情 DOI
6. Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphism.
   Mazda Adli, Dorothea L Hollinde, Thomas Stamm, Katja Wiethoff, Martina Tsahuridu, Julia Kirchheiner
   Biological psychiatry 2007 IF: 10.30 Q1 PMID: 17628506

   Glycogen synthase kinase 3-beta (GSK3B) is a serine/threonine kinase which is directly inhibited by lithium. A -50T/C single nucleotide polymorphism (SNP) localized within the promoter region of the G…

   查看详情 DOI
7. A longitudinal functional magnetic resonance imaging study of verbal working memory in depression after antidepressant therapy.
   Nicholas D Walsh, Steven C R Williams, Michael J Brammer, Edward T Bullmore, Jieun Kim, John Suckling
   Biological psychiatry 2007 IF: 10.30 Q1 PMID: 17601497

   Impairments in the neural circuitry of verbal working memory are evident in depression. Factors of task demand and depressive state might have significant effects on its functional neuroanatomy. Two g…

   查看详情 DOI
8. 5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depression.
   Gregor Hasler, Robert Bonwetsch, Giampiero Giovacchini, Maria T Toczek, Anto Bagic, David A Luckenbaugh
   Biological psychiatry 2007 IF: 10.30 Q1 PMID: 17588547

   Major depressive disorder (MDD) is the most common comorbid psychiatric condition associated with temporal lobe epilepsy (TLE). Preclinical and clinical studies suggest that 5-HT(1A) receptors play a …

   查看详情 DOI
9. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
   George I Papakostas, Michael E Thase, Maurizio Fava, J Craig Nelson, Richard C Shelton
   Biological psychiatry 2007 IF: 10.30 Q1 PMID: 17588546

   Recent studies suggest that the treatment of major depressive disorder (MDD) with newer antidepressant drugs that simultaneously enhance norepinephrine and serotonin neurotransmission might result in …

   查看详情 DOI
10. Frontal and limbic activation during inhibitory control predicts treatment response in major depressive disorder.
    Scott A Langenecker, Susan E Kennedy, Leslie M Guidotti, Emily M Briceno, Lawrence S Own, Thomas Hooven
    Biological psychiatry 2007 IF: 10.30 Q1 PMID: 17585888

    Inhibitory control or regulatory difficulties have been explored in major depressive disorder (MDD) but typically in the context of affectively salient information. Inhibitory control is addressed spe…

    查看详情 DOI